Updated: CMS picks Lilly’s Trulicity, Gilead’s Biktarvy for third round of Medicare negotiationsnews2026-01-27T22:26:48+00:00January 27th, 2026|Endpoints News|
Hospitals could earn more for buying US-made drugs, CMS proposesnews2026-01-27T20:05:47+00:00January 27th, 2026|Endpoints News|
Cardiff execs depart as company drops mixed Phase 2 datanews2026-01-27T18:22:21+00:00January 27th, 2026|Endpoints News|
UnitedHealth projects lower revenue in 2026 as it resets its businessnews2026-01-27T18:11:22+00:00January 27th, 2026|Endpoints News|
REGULATION OUTLOOK 2026: EU energy security vital amid geopolitical turmoilnews2026-01-27T17:33:00+00:00January 27th, 2026|Independent Commodity Intelligence Services (ICIS)|
Germany-Denmark green light on 3GW Bornholm Energy Island unlikely to drive German power prices – tradersnews2026-01-27T17:32:00+00:00January 27th, 2026|Independent Commodity Intelligence Services (ICIS)|
US commodity chemical imports from S Korea shrink amid new 25% tariff threatnews2026-01-27T17:22:00+00:00January 27th, 2026|Independent Commodity Intelligence Services (ICIS)|
